Skip to Main Content

Paper Details

Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.
Nat Commun
9
2022
Author NameAffiliation
Yiqun ZhangDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Lawrence D TrueUniversity of Washington
Daniel W LinUniversity of Washington
Colm MorrisseyUniversity of Washington
Chad J CreightonDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
  • 1 - 7

Datasets

Release 1.2